Gastric electrical stimulation with Enterra therapy improves symptoms of idiopathic gastroparesis

Neurogastroenterology and Motility

Volumn 25, Issue 10, 2013, Pages

  Mccallum, R W ^a   Sarosiek, I ^a   Parkman, H P ^b   Snape, W ^c   Brody, F ^d   Wo, J ^e   Nowak, T ^e  

^a Texas Tech University Health Sciences Center El Paso   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^d GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^e INDIANA UNIVERSITY   (United States)

Author keywords

Gastric stimulation; Gastroparesis; Idiopathic gastroparesis; Nausea; Vomiting

Indexed keywords

ADULT; ARTICLE; BODY MASS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTROSTIMULATION THERAPY; FEMALE; FOLLOW UP; HUMAN; LENGTH OF STAY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; STOMACH EMPTYING; STOMACH PARESIS; VOMITING;

GASTRIC STIMULATION; GASTROPARESIS; IDIOPATHIC GASTROPARESIS; NAUSEA; VOMITING;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FEMALE; GASTROPARESIS; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VOMITING; YOUNG ADULT;

EID: 84884727188     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/nmo.12185     Document Type: Article

References (29)

1. Soykan I, Sivri B, Sarosiek I, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998; 43: 2398-404.
2. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127: 2589-91.
3. Hasler WL. Gastroparesis: symptoms, evaluation, and treatment. Gastroenterol Clin N Am 2007; 36: 619-47.
4. Kong M-F, Horowitz M, Jones KL et al. Natural history of Diabetic Gastroparesis. Diabetes Care 1999; 22: 503-7.
5. Hasler WL. Gastroparesis-current concepts and considerations. Medscape J Med 2008; 10: 16.
6. McCallum RW, Soffer E, Pasricha J et al. Treatment of gastroparesis: a multidisciplinary clinical review. Neurogastroenterol Motil 2006; 18: 263-83.
7. Reddymasu S, McCallum RW. Pharmacotherapy of gastroparesis. Expert Opin Pharmacother 2009; 10: 1-16.
8. Arts J, van Gool S, Caenepeel P, Verbeke K, Janssens J, Tack J. Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther 2006; 24: 661-7.
9. Bromer MQ, Friedenberg F, Miller LS, Fisher RS, Swartz K, Parkman HP. Endoscopic pyloric injection of botulinum toxin A for the treatment of refractory gastroparesis. Gastrointest Endosc 2005; 61: 833-9.
10. US Food and Drug Administration. H990014-EnterraTM therapy system (formerly named gastric electrical stimulation (GES) system). p. 47. Available at: http://www.fda.gov/cdrh/ode/H990014sum.html. Accessed March 31, 2000.
11. McCallum RW, Lin Z, Forster J, Roeser K, Hou Q, Sarosiek I. Gastric electrical stimulation improves outcome of patients with gastroparesis for up to 10 years. Clin Gastroenterol Hepatol 2011; 9: 314-9.
12. McCallum R, Lin Z, Wetzel P, Sarosiek I, Forster J. Clinical response to gastric electrical stimulation in patients with postsurgical gastroparesis. Clin Gastroenterol Hepatol 2005; 3: 49-54.
13. Abell T, McCallum RW, Hocking M et al. Gastric electrical stimulation for medical refractory gastroparesis. Gastroenterology 2003; 125: 421-8.
14. Abell T, Lou J, Tabbaa M et al. Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up. J Parenter Enteral Nutr 2003; 27: 277-81.
15. Lin Z, Sarosiek I, Forster J, McCallum RW. Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil 2006; 18: 18-27.
16. McCallum RW, Pasricha PJ. Gastroparesis and gastric electrical stimulation: a useful option for gastroparesis. AGA Perspectives 2006; 2: 5.
17. Soffer E, Abell T, Lin Z et al. Review article: gastric electrical stimulation for gastroparesis - physiological foundations, technical aspects and clinical implications. Aliment Pharmacol Ther 2009; 30: 681-94.
18. Namin F, Lin Z, Sarosiek I, McCallum RW. Gastric electrical stimulation: who are the best candidates and what are the results. Pract Gastroenterol 2005; 8: 28-47.
19. House A, Champion MC, Chamberlain M. National survey of radionuclide gastric emptying studies. Can J Gastroenterol 1997; 11: 317-21.
20. Tougas G, Eaker EY, Abell TL et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol 2000; 95: 1456-62.
21. Forster J, Sarosiek I, Delcore R et al. Gastric pacing is a new surgical treatment for gastroparesis. Am J Surg 2001; 182: 676-81.
22. Ware JE, Kosinski M. SF-36 physical & mental health summary scales: a manual for users of version 1. In: QualityMetric. 2nd edn. Lincoln, RI: QualityMetric Incorporated, 2001.
23. Cutts TF, Luo J, Starkebaum W et al. Is gastric electrical stimulation superior to standard pharmacological therapy in improving GI symptoms, healthcare resources, and long-term health care benefits? Neurogastroenterol Motil 2005; 17: 35-43.
24. Lin Z, McElhinney C, Sarosiek I, Forster J, McCallum RW. Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalization. Dig Dis Sci 2005; 50: 1328-34.
25. McCallum RW, Snape W, Brody F, Wo J, Parkman HP. Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study. Clin Gastroenterol Hepatol 2010; 8: 947-54.
26. Bityutskiy L, Soykan I, McCAllum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis, clinical characteristics and long-term outcome. Am J Gastroenterol 1997; 92: 1501-4.
27. Pande H, Lacy BE, Crowell MD. Inflammatory causes of gastroparesis: report of five cases. Dig Dis Sci 2002; 47: 2664-8.
28. Revicki DA, Rentz AM, Dubois D et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141-50.
29. Rentz AM, Kahrilas P, Stanghellini V et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004; 13: 1737-49.